Jasper van Grunsven: Grateful for Our Rare Disease Team and the Commitment That Drives Our Mission
Jasper van Grunsven, Senior Vice President for Rare Disease, Global Customer Capabilities, Data and Analytics at Amgen, shared a post on LinkedIn:
“As I reflect on a week of engagement activities in Amgen Deerfield, I am filled with appreciation for our Rare Disease team and the passion and commitment that drive our work every day.
From bringing our senior leadership team together to align on shared priorities, to being inspired by our Patient Access colleagues and how they support patients, this week highlighted the strength of our people and our purpose.
One of the most impactful moments was hearing from Glen, who lives with severe active ANCA-associated vasculitis, during our Vasculitis Awareness Month spotlight at the Rare Disease Town Hall. His story was a powerful reminder of the challenges patients face and the meaningful difference we can make for them and their families when we work as One Team.
Thank you to everyone who made this week so memorable. I continue to be inspired by the dedication and passion across our organization as we work together to advance care for people living with rare diseases and to deliver on our mission for patients.”

Stay updated with Hemostasis Today.
-
Jul 13, 2026, 14:42Bruno Pougault: The Global Momentum Behind Innovation in Thrombosis and Hemostasis
-
Jul 13, 2026, 14:34Julie Vassart: Optimizing DOAC Detection in an Evolving Anticoagulant Landscape at ISTH 2026
-
Jul 13, 2026, 13:57Heghine Khachatryan: The Diagnostic Dilemma of Non-Criteria Obstetric APS
-
Jul 13, 2026, 13:49Mitra Najafi: Translating Years of Innovation into Global Scientific Dialogue at ISTH 2026
-
Jul 13, 2026, 13:2810 Posts Not To Miss from ISTH 2026, Part 2
-
Jul 13, 2026, 11:25Luisa Müller: Advancing Anticoagulation Strategies for VITT at ISTH 2026
-
Jul 13, 2026, 10:49Joshua Zeidner: Advancing Menin Inhibitor Therapy in MD Education AML-ALL US Focus 2026
-
Jul 13, 2026, 10:25Flora Peyvandi: A Practical Approach to ALT Elevation After Gene Therapy at ISTH 2026
-
Jul 13, 2026, 10:02Jessica Garcia: Where Science and Community Come Together at ISTH 2026